Innocoll is committed to building a portfolio of products that help solve some of today’s most important healthcare challenges. We are actively looking to build our company through the in-licensing or acquisition of registration phase and on-market therapies to increase our presence in the U.S. hospital and specialty therapeutic areas.

Outside of the U.S., we will continue to explore out-licensing opportunities for our products. We currently have a strategic partnership in place with SERB SA for COLLATAMP G® in a range of countries outside of the United States.

Business Development Contact: